Stockreport

KalVista Pharmaceuticals Presents Sebetralstat Data at Bradykinin Symposium 2024

KalVista Pharmaceuticals, Inc.  (KALV) 
Last kalvista pharmaceuticals, inc. earnings: 3/10 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.kalvista.com
PDF –Patient perspectives shed additional light on the challenges of treating hereditary angioedema attacks with injectable on-demand therapies––New analyses of sebetralstat [Read more]